374 related articles for article (PubMed ID: 11413297)
1. A single amino acid alteration in the human parainfluenza virus type 3 hemagglutinin-neuraminidase glycoprotein confers resistance to the inhibitory effects of zanamivir on receptor binding and neuraminidase activity.
Murrell MT; Porotto M; Greengard O; Poltoratskaia N; Moscona A
J Virol; 2001 Jul; 75(14):6310-20. PubMed ID: 11413297
[TBL] [Abstract][Full Text] [Related]
2. Mutations in human parainfluenza virus type 3 hemagglutinin-neuraminidase causing increased receptor binding activity and resistance to the transition state sialic acid analog 4-GU-DANA (Zanamivir).
Murrell M; Porotto M; Weber T; Greengard O; Moscona A
J Virol; 2003 Jan; 77(1):309-17. PubMed ID: 12477836
[TBL] [Abstract][Full Text] [Related]
3. Human parainfluenza virus type 3 HN-receptor interaction: effect of 4-guanidino-Neu5Ac2en on a neuraminidase-deficient variant.
Porotto M; Greengard O; Poltoratskaia N; Horga MA; Moscona A
J Virol; 2001 Aug; 75(16):7481-8. PubMed ID: 11462020
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of parainfluenza virus type 3 and Newcastle disease virus hemagglutinin-neuraminidase receptor binding: effect of receptor avidity and steric hindrance at the inhibitor binding sites.
Porotto M; Murrell M; Greengard O; Lawrence MC; McKimm-Breschkin JL; Moscona A
J Virol; 2004 Dec; 78(24):13911-9. PubMed ID: 15564499
[TBL] [Abstract][Full Text] [Related]
5. The anti-influenza virus agent 4-GU-DANA (zanamivir) inhibits cell fusion mediated by human parainfluenza virus and influenza virus HA.
Greengard O; Poltoratskaia N; Leikina E; Zimmerberg J; Moscona A
J Virol; 2000 Dec; 74(23):11108-14. PubMed ID: 11070006
[TBL] [Abstract][Full Text] [Related]
6. The use of a quantitative fusion assay to evaluate HN-receptor interaction for human parainfluenza virus type 3.
Levin Perlman S; Jordan M; Brossmer R; Greengard O; Moscona A
Virology; 1999 Dec; 265(1):57-65. PubMed ID: 10603317
[TBL] [Abstract][Full Text] [Related]
7. Contribution of the human parainfluenza virus type 3 HN-receptor interaction to pathogenesis in vivo.
Prince GA; Ottolini MG; Moscona A
J Virol; 2001 Dec; 75(24):12446-51. PubMed ID: 11711635
[TBL] [Abstract][Full Text] [Related]
8. Influence of the human parainfluenza virus 3 attachment protein's neuraminidase activity on its capacity to activate the fusion protein.
Porotto M; Murrell M; Greengard O; Doctor L; Moscona A
J Virol; 2005 Feb; 79(4):2383-92. PubMed ID: 15681439
[TBL] [Abstract][Full Text] [Related]
9. Paramyxovirus receptor-binding molecules: engagement of one site on the hemagglutinin-neuraminidase protein modulates activity at the second site.
Porotto M; Fornabaio M; Greengard O; Murrell MT; Kellogg GE; Moscona A
J Virol; 2006 Feb; 80(3):1204-13. PubMed ID: 16414997
[TBL] [Abstract][Full Text] [Related]
10. Virus-receptor interactions of human parainfluenza viruses types 1, 2 and 3.
Ah-Tye C; Schwartz S; Huberman K; Carlin E; Moscona A
Microb Pathog; 1999 Nov; 27(5):329-36. PubMed ID: 10545258
[TBL] [Abstract][Full Text] [Related]
11. A second receptor binding site on human parainfluenza virus type 3 hemagglutinin-neuraminidase contributes to activation of the fusion mechanism.
Porotto M; Fornabaio M; Kellogg GE; Moscona A
J Virol; 2007 Apr; 81(7):3216-28. PubMed ID: 17229690
[TBL] [Abstract][Full Text] [Related]
12. Triggering of human parainfluenza virus 3 fusion protein (F) by the hemagglutinin-neuraminidase (HN) protein: an HN mutation diminishes the rate of F activation and fusion.
Porotto M; Murrell M; Greengard O; Moscona A
J Virol; 2003 Mar; 77(6):3647-54. PubMed ID: 12610140
[TBL] [Abstract][Full Text] [Related]
13. Relative affinity of the human parainfluenza virus type 3 hemagglutinin-neuraminidase for sialic acid correlates with virus-induced fusion activity.
Moscona A; Peluso RW
J Virol; 1993 Nov; 67(11):6463-8. PubMed ID: 8411349
[TBL] [Abstract][Full Text] [Related]
14. Molecular basis for the resistance of influenza viruses to 4-guanidino-Neu5Ac2en.
Staschke KA; Colacino JM; Baxter AJ; Air GM; Bansal A; Hornback WJ; Munroe JE; Laver WG
Virology; 1995 Dec; 214(2):642-6. PubMed ID: 8553569
[TBL] [Abstract][Full Text] [Related]
15. Hemagglutinin-neuraminidase of human parainfluenza 3: role of the neuraminidase in the viral life cycle.
Huberman K; Peluso RW; Moscona A
Virology; 1995 Dec; 214(1):294-300. PubMed ID: 8525632
[TBL] [Abstract][Full Text] [Related]
16. Mutations affecting the sensitivity of the influenza virus neuraminidase to 4-guanidino-2,4-dideoxy-2,3-dehydro-N-acetylneuraminic acid.
Goto H; Bethell RC; Kawaoka Y
Virology; 1997 Nov; 238(2):265-72. PubMed ID: 9400599
[TBL] [Abstract][Full Text] [Related]
17. In vitro selection and characterisation of influenza B/Beijing/1/87 isolates with altered susceptibility to zanamivir.
Barnett JM; Cadman A; Burrell FM; Madar SH; Lewis AP; Tisdale M; Bethell R
Virology; 1999 Dec; 265(2):286-95. PubMed ID: 10600600
[TBL] [Abstract][Full Text] [Related]
18. Generation and characterization of an influenza virus neuraminidase variant with decreased sensitivity to the neuraminidase-specific inhibitor 4-guanidino-Neu5Ac2en.
Blick TJ; Tiong T; Sahasrabudhe A; Varghese JN; Colman PM; Hart GJ; Bethell RC; McKimm-Breschkin JL
Virology; 1995 Dec; 214(2):475-84. PubMed ID: 8553549
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the activities of zanamivir, oseltamivir, and RWJ-270201 against clinical isolates of influenza virus and neuraminidase inhibitor-resistant variants.
Gubareva LV; Webster RG; Hayden FG
Antimicrob Agents Chemother; 2001 Dec; 45(12):3403-8. PubMed ID: 11709315
[TBL] [Abstract][Full Text] [Related]
20. In vitro selection and characterization of influenza A (A/N9) virus variants resistant to a novel neuraminidase inhibitor, A-315675.
Molla A; Kati W; Carrick R; Steffy K; Shi Y; Montgomery D; Gusick N; Stoll VS; Stewart KD; Ng TI; Maring C; Kempf DJ; Kohlbrenner W
J Virol; 2002 Jun; 76(11):5380-6. PubMed ID: 11991966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
